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ABSTRACT
Malaria ranks among the foremost health issues facing tropical countries. In this paper, we
explore the determinants of cross-country differences in malaria morbidity, and examine the linkage
between malaria and economic growth.
Using a classification rule analysis, we confirm the dominant role of climate in accounting
for cross-country differences in malaria morbidity. The data, however, do not suggest that tropical
location is destiny: controlling for climate, we find that access to rural healthcare and income
equality influence malaria morbidity.
In a cross-section growth framework, we find a significant negative association between
higher malaria morbidity and the growth rate of GDP per capita which is robust to a number of
modifications, including controlling for reverse causation. The estimated absolute growth impact of
malaria differs sharply across countries; it exceeds a quarter percent per annum in a quarter of the
sample countries. Most of these are located in Sub-Saharan Africa (with an estimated average annual
growth reduction of 0.55 percent).
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Malaria ranks among the major health and development challenges facing some 
of the poorest economies.
2 Endemic in ninety-one countries, accounting for forty percent 
of the world’s population, malaria affects an estimated three hundred million people. 
Though in most cases treatable, malaria is responsible for more than a million deaths per 
year. In Sub-Saharan Africa, the most affected region, malaria related illnesses claim the 
life of one out of every twenty children below age five. For adults, mortality rates are 
lower but frequent debilitating attacks reduce the quality of life for chronic sufferers. 
 
The human and economic costs of malaria have been recognized for centuries.  
The unraveling of the transmission mechanism in the late 19
th century opened the way 
towards systematic anti-malarial efforts. Initially, these efforts focussed on controlling 
the population of anopheles mosquitoes transmitting the parasite. DDT based eradication 
programs achieved notable successes in countries with relatively low malaria incidence in 
the Mediterranean and in some Asian countries, but largely failed in high-incidence 
regions, notably in Sub-Saharan Africa, and were largely abandoned in the late 1960s. 
During the last decades, anti-malaria efforts have focussed primarily on reducing human 
exposure for given anopheles populations, primarily through the use of bednets and 
protective clothing, on reducing the health effects of malaria episodes, and more recently, 
on developing an effective vaccine.  
 
 
The partial success of the eradication programs resulted in a sharp spatial 
concentration of malaria in tropical areas. The same areas also suffer most from a set 
other illnesses related to the economic development stage [Sachs (1997, 1999), Gallup 
                                                            
2 The debate on the development effects of malaria reaches back to the early part of this century. Ross 
(1911), Carter (1919), Sinton (1935/36) and Macdonald (1950) are among the classic studies. Recent 
studies include Conley (1975), Aron and Davis (1993), Gomes (1993), Hammer (1993), Mills (1993), 
Chima and Mills (1998), Gallup and Sachs (1998), Gallup, Sachs and Mellinger (1998) and Goodman, 
Coleman and Mills (1998).    
   4 
and Sachs (1998a,b)], including intestinal diseases causes by contaminated water and 
communicable diseases such as tuberculosis.  
 
Morbidity and mortality rates for this last group of diseases are strongly linked to 
income per capita levels. The link is bi-directional: impaired public health restrains 
economic development, while economic development, by increasing access to clean 
water and sanitation and by improving housing conditions, reduces the morbidity rates 
for these diseases [Gallup, Sachs and Mellinger (1998)].  
 
Table 1: Malaria Mortality and Loss of DALYs in 1995 








Total  1110  793  272,925  39,267 
         
    Males  572  417  136,572  20,188 
    Females  538  376  136,353  19,080 
         
    High Income  0  …  …  0 
    Low Income  1110  …  …  39,267 
         
    Africa  961  745  237,647  34,506 
    Americas  4  0  2,043  130 
    Eastern  Mediterranean  53  36  13,693  1,854 
    Europe  0  0  0  0 
    South East Asia  73  10  15,791  2,185 
    Western Pacific  20  2  3,751  591 
Source: World Health Organization (1999).  
DALY: Disability Adjusted Life Years (Murray and Lopez (1996)). 
 
As a primarily rural parasitic disease transmitted by mosquito bites, malaria is less 
immediately affected by improved urban sanitation and housing in the course of 
economic development; indeed, after the failure of the eradication efforts, malaria has at 
times been portrayed as a largely unavoidable side effect of tropical location. The 
sizeable differences in malaria morbidity between countries with few geographic 
differences suggest, however, that location is not entirely destiny.  
   5 
Economic development may influence malaria morbidity by providing households 
with the means to invest in anti-malaria protection --- notably insecticide-impregnated 
bednets and protective clothing ---- and in full medical treatment cycles. Furthermore, 
governmental capacity to provide comprehensive access to rural healthcare and to engage 
in local mosquito control arguably increases with economic development.  To the degree 
that these channels are operative, malaria is as closely intertwined with development as 
the other tropical diseases most prevalent at early economic development stages.  
 
The core of this paper is devoted to the empirical analysis of these linkages. Our 
paper builds on a sizeable prior literature examining the incidence and economic cost of 
malaria, primarily with a household or site focus. The household/site-specific approach 
provides an intuitive and attractive cost-assessment methodology based on high quality 
local data. By construction, it is, however, less suited for exploring other relevant 
questions, including the impact of macro policy variables on malaria morbidity across 
countries, and the importance of indirect effects of malaria on total factor productivity. 
These issues, more readily addressed in a cross-country comparative framework, are the 
focus of the present paper. 
 
Based on morbidity data for a large group of countries in three five-year periods, 
we examine two issues. We begin by exploring the cross country differences in malaria 
morbidity rates to ask whether such differences are adequately explained by climate 
differences (the “location as destiny” view), or whether economic variables such as 
income distribution and health care availability provide important additional explanatory 
power. 
 
We then turn to the effect of malaria on economic growth in a standard cross-
section growth framework. The cross-section methodology allows us to explore not only 
the net effect of malaria on growth, but to also shed some light on the transmission 
channels. Adding a malaria variable to a standard growth equation allows the 
identification of any residual effect on productivity. Such effects may arise from a variety 
of sources, including the effect of repeated worker absences on production patterns and   6 
specialization, malaria-prevention motivated reductions in internal and external labor 
mobility, and the potential loss of investment projects in tourism and infrastructure.
3  
 
Our approach to the second question is most closely linked to a series of papers 
exploring the link between geography, economic development and diseases by Bloom 
and Sachs (1998), Gallup, Sachs and Mellinger (1998), and Gallup and Sachs (1998). The 
papers employ a malaria exposure index, defined as the product of the land area subject 
to malaria and the fraction of malaria cases attributable to the most serious malaria 
variant, to explore the growth and income effect of malaria in a cross country regression 
framework. Gallup, Sachs and Mellinger (1998) detect both a significant negative 
correlation between the 1994 malaria exposure index and the 1995 (log) income per 
capita level, and a significant positive association between declines in malaria exposure 
between 1966
4 and 1994 and the 1965 to 1990 per capita growth rate. Gallup and Sachs 




We extend this research in three directions, elaborated below. First, we use a 
panel data-set on malaria morbidity rather than exposure as our malaria measure. Second, 
we formally explore whether, controlling for climate, other variables principally 
susceptible to intervention are useful in determining differences in malaria morbidity 
between countries sharing the same climate characteristics.
6 Third, we explicitly 
distinguish between the effects of malaria on total factor productivity and indirect effects 
                                                            
3 Many of these effects involve hypothetical alternative histories; their empirical importance is very hard to 
establish. Examples abound, though, ranging from the perceived need to combat malaria as a pre-requisite 
for the construction of the Panama Canal to the positive effect of malaria eradication on Mediterranean 
tourism.  
4 The fraction of falciporum cases in total cases is available only for 1990. Under the assumption that the 
fraction is time invariant, malaria maps for 1966 and 1994 are digitized to derive the land share and create 
exposure indices for 1966 and 1994.  
5 For the exposure index to fall to zero, it must either be the case that the population of parasite carrying 
mosquitoes drops to zero, or that the fraction of the most serious parasite among all cases drops to zero. 
Our estimates, reported below, instead define the counterfactual as zero malaria morbidity, regardless of the 
malaria variety.  
6 Straus and Thomas (1998) provide a broad review of the links between health, nutrition and economic 
development.    7 
of malaria on growth operating through lower growth elasticities of human and physical 
investment.  
 
The remainder of the paper divides into five sections. We continue with a brief 
summary of the transmission mechanism and of the effects of malaria. We then describe 
the data before turning to classification rule analysis to examine the relative incidence of 
malaria across countries as a function of spatial, climatic and social factors. In section 






Malaria is a parasitic disease transmitted by anopheles mosquitoes. The human 
malaria exposure rate determined by the fraction of the mosquito population carrying the 
parasite
8; the life-expectancy of the mosquito relative to the parasite’s incubation period, 
the use of night-time protection, in particular bednets (most mosquito- bites occur 
between sunset and sunrise); the location of human populations relative to mosquito 
breeding grounds (the mosquito flight range is limited to about 2 miles) and temperature.
9 
The interplay of these factors results in significant cross-country differences in human 
exposure rate: estimates suggest that the number of infective bites per person per year 
ranges from zero in non-tropical areas to the low single digits in sub-tropic areas, and to 
between forty and more than a hundred bites in some tropical areas. For a variety of 
reasons, including climate and the spatial distribution of parasite and anopheles species, 
Sub-Saharan Africa suffers the highest exposure rates, followed by parts of Asia and 
Latin America.  
 
                                                            
7 For a detailed description of malaria, see Bruce-Chwatt (1985). Brinkmann and Brinkmann (1991) 
provide a concise treatment of malaria and health in Africa. 
8 Plasmodium falciparum, Plasmodium malariae, Plasmodium ovale and Plasmodium vivax. Plasmodium 
falciparum is associated with the most serious effects.  
9 At temperatures below 22 degrees Celsius, the ratio of the parasite’s incubation period relative to the 
expected mosquito lifetime increases rapidly. At 18 degrees Celsius, the incubation period, at 55 days, 
exceeds the lifespan of 99.7% of a mosquito cohort (Snow et al. (1999)).   8 
Over time, the human immune system adjusts to combating the malaria parasite. 
Adult mortality in endemic areas is hence fairly low, malaria mortality is concentrated 
among children between the age of six months and five years (the age at which the 
immunity inherited from the mother wanes and at the age at which children develop their 
own immunity), among travelers and migrants from non-malarial into malarial regions, 
among populations in previously non-malarial regions undergoing climatic change, and 
among populations with repressed immune system, including pregnant women and 
individuals suffering from HIV.   
 
A typical bout of malaria lasts from about ten to fourteen days
10, with four to six 
days of near complete incapacitation, and recuperation periods of four to eight days 
characterized by fatigues and weakness. Mild malaria is characterized by one or two 
episodes of malarial fever per year, coupled with headache, nausea, fatigue and diarrhea, 
with relatively few side effects between episodes. Severe malaria, primarily in 
Plasmodium falciporum infections most prevalent in Sub-Saharan Africa, results in 
impaired consciousness, weakness and jaundice, and accounts for most fatal cases.  
 
Anti-malaria efforts have been four-pronged, targeting the reduction of the 
mosquito population, the minimization of the number of infective bites for a given 
mosquito population, the development of anti-malarial drugs and the development of an 
effective vaccine. The control of the anopheles populations dominated in the early 
postwar period. Widespread use of DDT coupled with the coating and draining of 
breeding grounds resulted in a substantial reduction in mosquito populations and malaria 
morbidity in the sub-tropics, notably southern Europe (Spain, Greece) and parts of Asia 
(Malaysia, Singapore) from 1940 to the late 1960s, in turn fueling optimism that malaria 
could be rapidly eradicated: “For the first time it is economically feasible for nations, 
however underdeveloped and whatever the climate, to banish malaria completely from 
their borders.” [Russell (1955)]
11  
 
                                                            
10 Hempel and Najera (1998) and Snow (1998) provide detailed discussions. 
11 See also Pampana (1969).   9 
The optimism proved premature. While substantial inroads were achieved in the 
sub-tropics, controlling malaria in the tropics proved far more challenging. The 
combination of far higher human and mosquito parasite carrying rates, the prevalence of 
anopheles species particularly suited to malaria transmission, a climate conducive to all-
year exposure and the gradual development of insecticide resistance reduced the 
effectiveness of the eradication effort, while the evidence increasingly pointed to 
significant adverse side effects of a pervasive use of insecticides. In consequence, 
eradication plans were largely abandoned in the late 1960s. Malaria prevention efforts 
have since shifted towards more easily implementable local protection methods, 
focussing on partial controls of breeding grounds and in particular, on the use of 
insecticide impregnated mosquito bednets to minimize infective bites for a given 
mosquito population. 
 
Table 2: Malaria Mortality Rates  
(Per 100,000 population/Annum) 
  1900  1950  1970  1997 
Sub-Saharan Africa  223  184  107  165 
Rest of World  192  39  7  1 
        Source: World Health Organization (1999) 
 
Better medical treatment of infected individuals has been the second prong of the 
attack on malaria. A range of anti-malarials [Gilles (1991)]
12 are effective in eliminating 
parasites in the blood (though not in the liver) within a short time period, at a cost of one 
to five dollars per bout. Significant challenges remain, however, as selection pressures, 
coupled with incomplete treatment and eradication cycles, tilt parasite and carrier 
populations towards strains with greater resistance to commonly used anti-malarials and 
insecticides. Longer term, vaccination is viewed as the next significant step forward in 
reducing malaria morbidity and mortality.  
 
                                                            
12 Including Quinine, Chloroquine, Malarone™, Amodiaquine, Mefloquine™, Proguanil and Artenisnin.   10 
Over the course of the century, malaria mortality and, to a lesser extent, morbidity 
has sharply declined outside Sub-Saharan Africa, though at a decelerating rate. Sub-
Saharan Africa, only partially involved in the global eradication efforts, has not witnessed 
a commensurate decline in either mortality or morbidity; indeed, both absolute cases and 
mortality rates have recently trended upward [Table 2].
13 The sustainability of the decline 
outside of Sub-Saharan Africa remains in question. While medical advances, notably the 
expected advent of an effective vaccine, promise further reductions, natural climatic 
changes
14 coupled with the increasing mobility of the human hosts and, as a side effect, 
mosquitoes





The incidence of malaria, like most tropical diseases, is measured rather 
imprecisely, placing particular value on consistency in cross-country data. We rely on a 
recent dataset on malaria published by the World Health Organization (WHO) in its 
Weekly Epidemiological Record, 8/13/99, www.who.int/wer. As malaria outside the 0-5 age 
group primarily takes the form of repeated incapacitating but non-fatal episodes, we 
focus on total population morbidity per 100,000 population. The incidence of malaria 
varies sharply over time, depending on the particular climatic situation in a given year 
and other factors. As a single year’s cross section may thus not be representative, we 
employ five-year averages covering the years 1983-1987, 1988-1992 and 1993-1997.
 17 
Table 3 presents the joint frequency distribution of malaria morbidity per 100,000 
                                                            
13 It is possible that the increase partly reflects an increase in the fraction of cases reported.  
14 Sharp increases in malaria in South America have been attributed to changes in mosquito habitats caused 
by El Nino. 
15 “Airport malaria”, the infection of individuals living close to airports, is perhaps the best known instance 
of the mobility effect, though the number of cases is very small relative to the world wide incidence.  
Relatively little is known about the quantitative effect of the exposure of local non-infected mosquito 
populations to infected human hosts.  See also Singhanetra-Renard (1993) on the mobility-malaria link. 
16 See Nájera, Kouznetzsov and Delacollette (1998), Cruz Marques (1987), Kondrashin (1987), Veeken 
(1993), inter alia.  
17 The exposure index used by Gallup, Sachs and Mellinger (1998) and Gallup and Sachs (1998) is based 
on two individual datapoints, multiplying the fraction of a country’s area which is exposed to malaria in 
1994 with the fraction of falciparum cases in total cases in 1990. We do not distinguish between 
Plasmodium varieties. The use of actual morbidity ratios rather than exposure has the advantage of 
controlling for differing uses of protective measures (and thus for the possibility that actual morbidity ratios   11 
population for all thee periods, revealing the large spread between near-zero morbidity 
rates at the bottom, and morbidity rates above ten percent (and for Sub-Saharan Africa 
above twenty percent) for the top decile. 
 
Table 3: Country Distribution of Malaria Morbidity  
(Cases per 100,000 population) 
Median 
All Years 




th  7.5  47.5       
25
th  75.9  1358.4    1983  495.9 
50
th  576.7  5043.3    1988  485.1 
75
th  4236.2  10155.2    1993  751.5 
90
th  11365.9  23354.6       
Source: Computed based on WHO (1999).  The percentile distribution is  
based on all available five-year averages (a maximum of three per country). 
 
We complement the malaria data by information on climate and location, on 
public health expenditures, access to clean water and sanitation and a range of socio-
economic indicators taken primarily from World Bank and WHO sources. Some of these 
data are only available at infrequent intervals. To match the malaria morbidity data and 
reduce endogeneity problems, observations for the years 1983, 1988 and 1993 (the 
starting years of the malaria five-year averages) were used where possible, else the 





Endemic malaria has been depicted as an unavoidable side effect of a tropical 
location. A first look at the data supports this view, malaria, not surprisingly, is 
concentrated in the tropics. Yet, a closer look within the tropics reveals substantial 
                                                                                                                                                                             
differ sharply between countries with similar exposure), while the averaging over multiple years reduces 
the importance of year to year fluctuations.  
18 The quality of the underlying data unavoidably differs across sources, as well as across countries for 
given sources. To reduce sensitivity to extreme measurements, all data were plotted, and obvious outliers 
removed, typically one or two per variable, with outliers often twenty to thirty times larger than the cluster 
of observations.   12 
differences in malaria morbidity and mortality rates between countries sharing similar 
locations and climates, suggesting the possibility of important additional determinants. 
We hence begin the exploration of the malaria-growth nexus by asking whether 
knowledge of climate is sufficient to explain the spatial pattern of malaria. If so, malaria 
can be viewed as an exogenous variable in growth regressions. If, in contrast, other 
variables, including some potentially influenced by economic development, play an 
additional independent role, a simultaneity problem arises.  
 
Box 1: Classification Tree Methodology 
Classification trees consist of a sequence of rules for predicting the value of a binary 
dependent variable based on a vector of independent variables. For the present purpose, the 
binary variable is defined as high (1) and low (0) malaria morbidity. We convert the continuos 
data into binary form by sorting the morbidity rates by size into three groups. The middle group is 
dropped, and observations in the top and bottom group are coded respectively as “1” (high 
morbidity) and “0” (low morbidity). 
 
The objective of classification tree analysis is to determine the set of rules (consisting of 
a discriminant variable and a threshold) which permits the best sorting of the dependent variable 
into its two constituent groups. At each branch of the tree, the sample is split based upon a 
threshold value of one of the explanatory variables into two sub-branches. The splitting is 
repeated along the various sub-branches until a terminal node is reached. Suppose, for example, 
that in all countries falling into the “high” group, the average annual temperate is above 27°  
Celsius, while in all countries falling into the “low” group, the average annual temperature is 
below 27° .  In this case, the rule average annual temperature is below 27°  ! low morbidity 
perfectly discriminates between the two groups, and the resulting decision tree would have a 
single branching with two nodes. In practice, perfectly discriminating rules are rare, and rules 
have associated type I and type II errors. In this case the algorithm selects the rule (consisting of 
the variable and the associated threshold) which minimizes a weighted sum of type I and type II 
errors. For the present purpose, equal weights are used. By construction, any additional sub-
branch reduces the overall error rate of the classification scheme. Akin to an adjusted R
2 criterion, 
the algorithm terminates at a node if the reduction in the overall error rate falls short of a penalty 
on the number of branches.  
 
Binary classification trees possess a number of advantages for the problem at hand. First, 
the algorithm establishes a priority ordering among the potential discriminants, discarding 
secondary variables and thus reducing the need for subjective pre-parsing. Second, the procedure 
permits subsamples to be described by different rules, thus allowing for context dependence. 




   13 
  The linkages are likely to be subject to threshold effects, for example the 
temperature-malaria link discussed above. In addition, the linkages may be subject to 
context-dependence. In particular, even if a cold average temperature is sufficient to infer 
low malaria morbidity, temperatures above this level may only be necessary but not 
sufficient to infer high malaria morbidity. To allow for these non-linearities, we turn to 
classification rule analysis to explore the determinants of different malaria morbidities. 
As the methodology has been used infrequently in economics, Box 1 provides a brief 
exposition.  
 
We use three groups of potential discriminants. The first covers spatial and 
climate variables capturing the suitability of the country as an anopheles habitat. It 
includes elevation, average annual temperature, average annual rainfall, the absolute 
latitude (proportional to the distance from the equator) and a dummy for adjacency to an 
ocean.
19 The second group of variables, proxying for the quality and accessibility of the 
public health system, includes the fraction of GDP spent on health care; the fraction of 
the population with ready access to health care (in the aggregate and separately for rural 
and urban areas); access to clean water and sanitation (in the aggregate and separately in 
rural and urban areas) and, as an alternative measure of exposure to water born diseases, 
mortality from intestinal infectious diseases. The third group --- aiming to capture any 
remaining individual or societal effects --- comprises GDP per capita
20, the percentage of 
the population living below the poverty line
21 and the Gini coefficient
22 as measures of 
household ability to invest in protective measures and medicine.  
 
The resulting classification rules are graphed in Table 4. The distance from the 
equator, as measured by the absolute latitude, is the single best and clearly exogenous 
discriminant between the high and low malaria morbidity group: seventy-three percent of 
                                                            
19 As climatic conditions often vary strongly within a country, elevation, temperature, absolute latitude and 
rainfall are averaged across the three largest cities for the ten largest countries. The other data are for the 
capital city. 
20 To the extent that a high malaria incidence reduces growth prospects, the causality is of course two-
sided, a point to which we return below. 
21 Based on UNDP, Human Development Report. 
22 Based on Deininger and Squire (1996), in a few cases updated from the World Bank World Development 
Indicators. The definition is standard; a higher coefficient denotes reduced income equality.   14 
the countries close to the equator fall into the high malaria group, contrasted with only 
fourteen percent of the countries located further away. 
 
Yet, while geography clearly matters [Gallup, Sachs and Mellinger (1998)], it is 
not destiny: among the countries sharing a location close to the equator, income 
distribution makes a small but noticeable difference: poverty ratios below eighteen 
percent are associated with a lower probability of belonging to the high malaria group 
(0.667 versus 0.745 for countries with larger poverty ratios). The interpretation of this 
link is however impeded by potential simultaneity. For a given GDP per capita, lower 
poverty ratios enable even poorer households to invest in anti-malaria measures, 
generating a causal link from lower poverty ratios to reduced malaria morbidity. Yet 
malaria itself reduces household incomes of those affected, and thus may increase 
poverty ratios in the absence of comprehensive social security systems. 
 
Moving down two nodes reveals that among countries located in close proximity 
to the equator, having high poverty ratios and relatively low access to rural healthcare, a 
real GDP per capita above 2,370 US$ is associated with a sharply lower (indeed, zero) 
probability of belonging to the high malaria group. The result is not surprising: the link 
between GDP per capita and malaria is well documented [Gallup, Sachs and Mellinger 
(1998)], indeed, it motivated much of the early work on malaria. Yet, again the 
interpretation is ambiguous as higher income (notably if associated with greater 
administrative capacity) enables improved anti-malaria efforts, while malaria itself 
undermines productivity and thus reduces income per capita. 
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Table 4: Classification Tree: Incidence Of High Versus Low Morbidity 
 
                    Full Sample   
                      (0.50)
23 
                                        |  
 115                                 |                                73 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
|                                                                          | 
|                                                                          | 
                    Abs. Latitude <= 18.3                                      Abs. Latitude > 18.3 
(0.730)                   (0.137) 
     |                                                                           
               21                 |               94                                                               
              - - - -- - - - - - - - - - - - - -                                       
              |                                       |                                                                              
              |                                       |                                                                              
Poverty <= 0.1825     Poverty > 0.1825       
 (0.667)                (0.745)                               
                                                | 
"                  4                             |                        90 
                      - - - - - - - - - - - - - - - - - - - - - - - - - - 
                      |                                                          | 
                      |                                                          | 
 Rural Health Access > 96.5               Rural Health Access <= 96.5 
                 (0.500)                                               (0.756) 
                                                                                 | 
                                                               10              |              80 
                                                                - - - - - - - - - - - - - - - - 
    |                                   | 
    |                                   | 
GDP p.c. > 2370  GDP p.c. <= 2370
24 
       (0.000)              (0.850) 
                             | 
               9             |                70 
              - - - - - - - - - - - - - - - - 
               |                                   | 
              |                                   | 
               Rain  <= 319                 Rain > 319 
                         (0.333)                     (0.929) 
 
                                                            
23 In brackets: Fraction of observations at the node belonging to the high malaria incidence group. The 
numbers at the branches refer to the number of observations at each branch.   
24 One additional node conditional on the Gini coefficient (<32.7) separates just a single (low mortality) 
observation and is not plotted for space reasons. The number of observations at the last split is thus 79 
rather than 80.    16 
 
The small set of classification rules correctly classifies 78 of the 94 high malaria 
cases and 71 of the 94 low malaria cases. Overall, 149 out of 188 observations were 
correctly identified (79%), compared to an expected 94 correct classifications (50%) 
using a purely random allocation.  
 
The classification rule methodology can also be used to rank variables by their 
overall power as a discriminant. The score for each variable is based on the difference in 
discriminatory power between the best discriminant at a particular node, and the 
discriminatory power of the variable in question, summed over all nodes. Good 
alternative rules are thus credited relative to bad alternative rules. As the score is 
computed over all nodes, it will in general not overlap with the ordering of splits in the 
tree, nor is it even necessary for a variable to appear in any rule in order to be important 
as a discriminant, provided it is a close competitor to the best rule at several nodes. Table 
5 reports the resulting ranking of variables by their power as discriminants. The second 
column provides a numerical measure of the power, scaled relative to the best 
discriminant. 
 
Table 5: Ranking Of Variables by Overall Discriminatory Power 
Variable  Power 
GDP per capita  100 
Poverty Ratio  62 
Access to Rural Healthcare  55 
Absolute Latitude  47 
Average Annual Rainfall  29 
Average Annual Temperature  17 
Gini Coefficient  14 
 
  GDP per capita emerges as the best overall discriminant (it appears as a strong 
competitor at the first three nodes); followed by the poverty ratio and access to rural 
healthcare, while the unambiguously exogenous discriminants --- latitude, temperature   17 
and rainfall --- enter lower, at ranks four to six. While the methodology does not address 
causality, and indeed GDP per capita itself may be partly endogenous to location [Gallup, 
Sachs and Mellinger (1998)]; the negative link between malaria and more equal income 
distribution and in particular access to rural health care is suggestive.  
 
5. Growth Effects of Malaria 
 
Malaria potentially affects both the volume and the productivity of inputs.  On the 
most direct level, malaria incapacitates part of the labor force. This loss of labor input has 
been the primary focus of the classic aggregate studies of malaria [Ross (1911), Sinton 
(1935-36)], and has been refined in several careful case studies. The consensus estimates 
suggest that attacks, depending on severity, typically entail a loss of four or more 
working days, followed by additional days with reduced work capacity [Brohult et al. 
(1981), Sheppard et al. (1991), Picard and Mills (1992), Hempel and Najera (1998)]. The 
output effect of the lost work time depends both on the degree to which other family-
members can increase work effort and, in agricultural areas, on the overlap between 
malaria episodes and harvest periods.
25  A second effect operates longer term: malaria 
attacks are a major cause of school absenteeism [McDonald (1950), Wernsdorfer and 
Wernsdorfer (1988)] and appears to negatively impact long term learning capacity; 
reducing the accumulation of human capital over time.  
 
These direct effects are augmented by more indirect links between malaria and 
productivity. Frequent absenteeism reduces the efficiency of networks, requiring greater 
redundancy and reducing the scope for specialization. Malaria motivated limits on 
mobility (both intra- and inter-national) reduce the quality of skill matching. Malaria 
induced changes in planting patterns to minimize the overlap between malaria episodes 
and peak agricultural work times reduce agricultural productivity [Conly (1975)]. 
                                                            
25 Malaria fevers tend to overlap with planting season in spring, while malignant tertian in autumn overlaps 
with the harvest season [Hempel and Najera (1996)].   18 
Endemic malaria also reduces the growth potential for some industries, notably tourism, 
and sharply raises the cost of infrastructure projects and other collective enterprises.
26 
 
  These indirect costs --- education never received, tourism and infrastructure 
projects never undertaken, specialization patterns never pursued --- are harder to estimate 
directly. They can however be indirectly captured in the residual of growth regressions: 
to the degree that malaria, controlling for other factors, exerts a significant adverse effect 
on growth, one would expect to find a significant explanatory role for malaria in standard 
growth regressions [Gallup and Sachs (1998), Gallup, Sachs and Mellinger (1998)]. 
 
Table 6: Medians 









Malaria Morbidity (per 100,000)  30  574  6697 
GDP per capita (Start of Period)  3595  2193  1267 
Average GDP p.c. Growth Rate (5Y)  1.45  1.51  0.22 
Investment Ratio  22.7  20.0  18.3 
Primary Enrollment Ratio  104  99  76 
Secondary Enrollment Ratio  49  35  16 
Absolute Latitude  25.5  14.0  9.4 
  Sources: See section three. 
 
  Table 6 provides some background information on important growth factors, 
based on sorting observations by malaria morbidity into three equal sized groups (low, 
medium, and high). For each group, the median value for each variable is reported. The 
third of countries with the highest malaria morbidity rates has not only the lowest initial 
GDP per capita --- a result brought out by the classification trees reported above --- but 
                                                            
26 As mentioned above, early anti-malaria measures in Panama were partly motivated by the perceived 
negative impact on the building of the canal. Malaria has also been cited as a major obstacle in the building 
of the trans-amazonian highway, of major dams and of tourism projects [Hempel and Najera (1996)].   19 
also the lowest growth rates of output per capita, and levels of human and physical 
capital. 
 
Table 7 reports a set of standard growth regression for the three periods (1983-88, 
1988-93, and 1993-98). The dependent variable for the core regressions presented in this 
table and for the robustness tests reported in table 8 is the average per capita growth rate 
in the three five year periods. The top two rows denote sample and regression technique. 
We report results both for pooled data and for seemingly unrelated regressions (SUR). 
The sample either comprises all observations or is limited to Sub-Saharan Africa.  
 
The coefficient pattern of the standard determinants is familiar: investment enters 
positive and is mostly significant. Primary and secondary education enter positive with 
one exception, though only secondary education is significant in some cases. Initial 
income per capita enters negatively, indicating conditional convergence; openness is 
positive and significant, while higher government consumption ratios enter negatively – 
and, for the full sample regressions, significant. Greater political freedom and stability, 
measured by the standard set of proxies --- the number of revolutions and assassinations 
and an index of political freedom
27 --- are associated positively, and in most cases 
significantly, with growth. 
 
Malaria enters negatively and significantly in all six regressions. The coefficient 
is very similar for all six regressions, specifically; there is no sizeable difference between 
the pooled regression and the SUR.  
 
It might of course be the case that the malaria variable simply proxies for other growth 
retardants common to the high malaria countries. To test for this possibility, we restrict 
the sample to Sub-Saharan Africa, and add dummies for Sub-Saharan Africa and Latin 
America to the full sample regression. Neither modification substantially alters the 
coefficient on malaria morbidity. 
                                                            
27 The political freedom index is from Freedom House; a higher value indicates lower freedom. The 
revolution and assassination data were kindly provided by Bill Easterly, the original source is Arthur S. 
Banks Cross-National Time-Series Data Archive.   20 
 
  Table 7: Regression Results    
          
Estimation  Pooled Pooled Pooled  SUR  SUR  SUR   
Technique  All Countries  Africa  All Countries All Countries  Africa  All Countries   
          
Constant  10.063** 16.212**  9.719**  10.283** 14.179** 10.349**   
  (2.601) (7.828) (2.823) (2.993) (5.868) (2.985)   
          
Investment    0.101** 0.017  0.054 0.092** 0.051  0.048   
Ratio  (0.044) (0.029) (0.045) (0.030) (0.048) (0.032)   
          
Primary    0.001 0.001 0.010 0.0004  -0.003 0.007   
Enrollment  (0.013) (0.013) (0.012) (0.012) (0.016) (0.012)   
          
Secondary    0.033*  0.078**  0.015  0.036**  0.076**  0.016   
Enrollment  (0.019) (0.037) (0.018) (0.015) (0.033) (0.016)   
          
Ln GDP p.c.   -1.272**  -2.339*  -0.952**  -1.302**  -2.025**  -1.018**   
(Initial)  (0.433) (1.210) (0.467) (0.397) (0.865) (0.401)   
          
Openness    0.013*  0.033** 0.017** 0.016** 0.030** 0.021**   
(Trade/GDP)  (0.007) (0.014) (0.007) (0.008) (0.012) (0.008)   
          
Gov.  Cons.    -0.124** -0.058 -0.137**  -0.128** -0.076 -0.140**   
(%  GDP)  (0.044) (0.042) (0.039) (0.036) (0.054) (0.035)   
          
Political    -0.228** -0.312** -0.298**  -0.195  -0.327*  -0.263**   
Freedom  (0.113) (0.151) (0.120) (0.123) (0.181) (0.123)   
          
Revolutions    -0.865** 0.184 -0.849**  -0.810** 0.316 -0.862**   
per  year  (0.427) (0.469) (0.408) (0.380) (0.621) (0.371)   
          
Index of   -0.012  -2.039*  -0.004  0.004  -2.523  -0.008   
assassinations  (0.071) (1.134) (0.080) (0.179) (1.503) (0.178)   
          
Sub  Saharan    -1.281**     -1.612**   
African  dummy     (0.534)     (0.594)   
          
Latin  American     -2.101**     -2.098**   
dummy     (0.557)     (0.647)   
          
Malaria morbidity  -0.000062**  -0.000073**  -0.000062**  -0.000064**  -0.000062*  -0.000061**   
(per  100,000)  (0.000028) (0.000035) (0.000028) (0.000029) (0.000031) (0.000028)   
          
R
2  0.27 0.24 0.32  -  -  -   
Obs.  187  81  187  59, 62, 66  22, 29, 30  59, 62, 66   
 
Dependent Variable: Average Per Capita Growth.  Standard errors (in brackets) are corrected for heteroskedasticity 
and correlation within country clusters for pooled regressions.  *(**) denote significance at the 10% and 5% level.   21 
 
Table 8 reports a set of robustness tests. To allow for the possibility that results 
are driven by outliers, columns two and four report the results obtained by replacing the 
malaria morbidity rate by a dummy set equal to one for the one third of observations with 
the highest morbidity rates. The dummy enters negatively, barely insignificant for the 
pooled regression (the p-value is 0.11) and significant for the SUR.  
 
The results reported in the previous section suggest a possible two-sided causality 
between malaria and economic growth, operating through the ability of the population to 
invest in anti-malaria protection in addition to the adverse growth effects described 
above. If so, the parameter estimates presented in Table 7 are subject to simultaneity bias.  
To examine this possibility, the first column of Table 8 substitutes current with lagged 
malaria. The substitution comes at the cost of losing the first sample period; the number 
of observations hence drops from 187 to 128. The coefficient on malaria is slightly larger 
in absolute terms and remains highly significant, consistent with a causal effect of 
malaria on growth. The results of using SUR rather than pooled estimation (reported in 
column 3) are similar. The two right-most columns report the results obtained for the 
growth rate over the entire fifteen-year period for OLS (column 5) and for TSLS (column 
6), using absolute latitude, average rainfall, temperature and an Africa dummy as 
instruments.
28 The fit of the first stage equation is fair, with an R2 of 0.40. With this 
caveat, the coefficient on malaria remains negative and significant at the ten-percent 
level. While larger in absolute terms, a Hausman test fails to reject the null hypothesis of 
parameter equality for the OLS and TSLS regressions.  
 
Overall, the robustness tests do not suggest that either the potential endogeneity of 
malaria morbidity or outliers drive the results. Beyond this direct effect, malaria might 
also indirectly affect growth through some of the standard growth determinants, notably 
physical and human capital accumulation.  
                                                            
28 To reduce endogeneity issues for the standard determinants, notably the investment ratio, we use 
beginning of period values. The set of instruments passes an over-identification test. The significance 
values are based on White-robust standard errors.   22 
 
   Table 8: Robustness Tests (All Countries)   
        
Estimation   Pooled  Pooled  SUR  SUR  OLS  TSLS 
Technique  lagged malaria lagged malaria  1983-98  1983-98 
  malaria dummy malaria dummy     
        
Constant  8.365** 10.094** 8.257** 10.355**  10.764**  15.331** 
  (2.756) (2.594) (3.314) (3.037) (3.378) (5.368) 
        
Investment    0.088*  0.096** 0.099** 0.087**  0.119*  0.120 
Ratio  (0.046) (0.045) (0.036) (0.031) (0.071) (0.073) 
        
Primary    0.0002 -0.002 -0.001 -0.005 -0.002 0.011 
Enrollment  (0.013) (0.012) (0.013) (0.011) (0.021) (0.028) 
        
Secondary    0.033*  0.034*  0.034**  0.036**  0.044  0.011 
Enrollment  (0.018) (0.019) (0.017) (0.015) (0.033) (0.043) 
        
Ln  GDP  p.c.    -1.053** -1.221** -1.064** -1.247** -1.425** -2.123** 
(Initial)  (0.468) (0.429) (0.446) (0.393) (0.498) (0.713) 
        
Openness    0.015** 0.011  0.016* 0.015*  0.006  0.032 
(Trade/GDP)  (0.007) (0.008) (0.008) (0.008) (0.012) (0.024) 
        
Gov.  Cons.    -0.133** -0.121** -0.139** -0.125**  -0.059  -0.056 
(%  GDP)  (0.047) (0.046) (0.041) (0.036) (0.061) (0.074) 
          
Political    -0.104 -0.197* -0.095  -0.166  -0.380**  -0.387 
Freedom  (0.120) (0.114) (0.141) (0.124) (0.182) (0.281) 
        
Revolutions    -0.721 -0.822* -0.692  -0.762** 0.135  0.258 
per  year  (0.520) (0.437) (0.425) (0.379) (0.657) (1.003) 
        
Index  of    -0.058 -0.027 -0.083 -0.021 -0.704 -0.640 
assassinations  (0.079) (0.073) (0.182) (0.180) (2.100) (2.277) 
        
Malaria  morbidity    -0.000089** -1.0541# -0.000090** -1.180** -0.000058**  -0.000287* 
    (0.000026) (0.660) (0.000035) (0.585) (0.000027)  (0.000162) 
        
R
2  0.28  0.26 -  - 0.42 - 
Obs.  128  187  0, 61, 67  59, 62, 66  54  53 
        
Standard errors for OLS are computed using White's robust procedure.  #: p-value is 0.11. 
If a dummy is included for Africa and Latin America, then all malaria measurements 
(except malaria dummy) remain significant at 10% level.     
   23 
 
To examine these effects, we estimate SURs of investment and the enrollment 
ratios
29 on a constant, the log of GDP per capita and malaria (t-statistics in brackets): 
 
Primary enrollment ratio     =  -50.06    +  18.36  Log(GDPpc)  - 0.00014 Malaria 
                                                 (-3.02)        (8.53)**                      (0.90)            
 
Secondary enrollment ratio =  -100.21 + 17.87  Log(GDPpc)   - 0.00021 Malaria 
                                                 (-7.39)     (10.19)**                      (-1.56)        
 
Investment ratio               =     -0.12  +   2.80  Log(GDPpc)   -0.000033 Malaria 
                                                   (0.01)      (2.90)**                      (0.38)         
 
 
For all three variables, malaria enters with a negative coefficient, though only the 
effect on secondary enrollment comes close to statistical significance at the ten- percent 
level. The results thus provide only muted support for an indirect negative effect of 
malaria on growth. The weak evidence may however reflect data problems, specifically; 
the lack of quality adjusted human and physical investment data. A child suffering from 
malaria, and consequently receiving a less effective education due to absences and 
reduced learning capacity, would still be counted in enrollment figures; while shifts in the 
composition of investment allowing for greater redundancy in endemic areas at the cost 
of reduced overall investment productivity would not necessarily be captured in the 
volume of investment. To the extent that these quantity/quality data problems are present, 
the malaria dummy in the regressions reported in Tables 7 and 8 would also pick up the 
indirect effect. A formal test of this possibility --- introducing interactive effects between 
morbidity and the accumulation factors into the regression --- however does not yield a 
significant effect for either human or physical capital accumulation. 
 
 
                                                            
29 The enrollment ratios are only available for the years 1985, 1990 and 1995. The investment ratio is the 
average of the five-year period.   24 
 
Table 9: Hypothetical Growth Effect of Eliminating Malaria Morbidity
Country Year Loss Country Year Loss
Malawi 1993 3.22 Guatemala 1988 0.035
The Gambia 1988 2.22 Suriname 1983 0.035
Solomon Islands 1993 1.81 Ecuador 1988 0.029
Sao Tome Principe 1983 1.79 Thailand 1988 0.029
Togo 1988 1.76 Ethiopia 1988 0.023
Namibia 1993 1.56 Bolivia 1988 0.023
Zambia 1988 1.52 Brazil 1993 0.017
Kenya 1983 1.28 Swaziland 1983 0.017
Vanuatu 1983 1.26 Vietnam 1988 0.017
Tanzania 1993 1.12 Colombia 1983 0.017
Guinea-Bissau 1993 0.98 India 1983 0.017
Rwanda 1993 0.90 Haiti 1988 0.017
Burundi 1988 0.70 Myanmar 1993 0.017
Ghana 1988 0.61 Malaysia 1983 0.017
Angola 1988 0.59 Peru 1983 0.012
Niger 1988 0.51 Philippines 1988 0.012
Gabon 1983 0.46 U.A.E. 1988 0.012
Cameroon 1988 0.42 El Salvador 1988 0.012
Liberia 1983 0.38 Yemen 1988 0.012
Cote d’Ivoire 1983 0.38 Sudan 1988 0.006
Burkina Faso 1988 0.37 Nepal 1988 0.006
Benin 1983 0.37 Iran 1993 0.006
Senegal 1983 0.35 Turkey 1983 0.006
Zimbabwe 1993 0.31 Saudi Arabia 1993 0.006
Equatorial Guinea 1983 0.30 Venezuela 1983 0.006
C.A.R. 1988 0.27 Costa Rica 1988 0.006
Papua New Guinea 1993 0.26 Pakistan 1983 0.006
Guyana 1988 0.26 Mexico 1988 0.006
Mauritania 1983 0.24 Paraguay 1983 0.006
Chad 1988 0.24 Indonesia 1993 0.006
Madagascar 1988 0.22 Somalia 1983 0.006
Bhutan 1988 0.19 Bangladesh 1988 0.006
Comoros 1993 0.19 Cape Verde 1983 0.000
Eritrea 1993 0.15 Congo 1988 0.000
Mali 1993 0.14 Iraq 1988 0.000
Belize 1983 0.13 Dominican Republic 1993 0.000
French Guyana 1983 0.13 Panama 1993 0.000
Sri Lanka 1983 0.12 South Africa 1988 0.000
Uganda 1988 0.09 Tajikistan 1988 0.000
Afghanistan 1983 0.09 China 1988 0.000
Guinea 1988 0.09 Maldives 1993 0.000
Botswana 1988 0.09 Mauritius 1983 0.000
Oman 1988 0.09 Armenia 1983 0.000
Congo, Dem. Rep. 1988 0.08 Argentina 1993 0.000
Cambodia 1983 0.08 Algeria 1983 0.000
Nigeria 1988 0.07 Morocco 1983 0.000
Honduras 1993 0.07 Syria 1988 0.000
Nicaragua 1988 0.06 Korea 1983 0.000
Lao PDR 1988 0.05 Azerbaijan 1988 0.000
Djibouti 1993 0.05 Egypt 1988 0.000  25 
 
Pulling these findings together, how much lower is the growth rate in endemic 
areas because of malaria? Under the very stringent assumption that the same growth 
elasticity of malaria morbidity applies to all countries and at all malaria morbidity rates, 
the product of the elasticity and the actual malaria morbidity in a country provides an 
estimate of the negative growth effect. Table 9 reports the results of this exercise, using 
the –0.000064 coefficient from the SUR regression for all countries reported in column 
four of table 7. To provide a conservative estimate, we used the median morbidity 
observation for countries with three observations, and the lower morbidity rate for 
countries with only two observations. The year noted specifies the beginning of the five-
year period used. Thus, considering the first row, for Malawi the predicted growth effect 
of reducing malaria to zero for the 1993 to 1998 period is 3.22 percent per annum. 
 
Table 10: Cost Per DALY Averted (US$, Midpoints) 
Intervention  $ per DALY 
Saved 
% Increase of 
Health Budget 
Better access to 2
nd and 3
rd line drugs  1.4  0.3 
Better compliance with drug therapy  4  0.5 
Insecticide treatment of existing nets  6  3.0 
One spraying round per year  22  27 
Chloroquine prophylaxis  43  0.2 
Distribution and treatment of nets  44  24.0 
      Source: WHO (1999:57). DALY: Disability Adjusted Life Year. The health budget  
      baseline is the public sector health budget for a typical low income Sub-Saharan  
      country. 
 
 Taken at face value, the results suggest that for many countries the growth cost of 
malaria is quite pronounced. Even disregarding the tails of the distribution, the estimated 
growth reduction due to malaria exceeds a quarter of a percent per year for about a 
quarter of the sample. The findings compares with earlier point GDP cost estimates for 
all of sub-Saharan Africa of 0.6 percent (predicted to rise to one percent) by Shephard, 
Ettling, Brinkman and Sauerborn (1991) and of 1.3 percent by Gallup and Sachs (1998) 
and Gallup, Sachs and Mellinger (1998). As the elasticity of growth with respect to 
malaria is unlikely to be invariant across countries, if only because the non-linear effects   26 
examined above in studying the incidence of malaria may also affect its economic costs, 
the point estimates should be viewed with a grain of caution. 
 
From a policy perspective, the economic and non-economic benefits of reducing 
malaria must be weighted against the costs of anti-malaria measures and contrasted with 
the cost-benefit calculus for other prevalent diseases. Detailed case studies suggest that 
substantial reductions can be obtained by fairly simple, low cost measures (Table 10) 
such as pre-packaging complete treatments, better education regarding the need to 
complete treatment cycles, better availability of second and third line drugs in areas with 




  Malaria ranks among the major health problems facing many developing 
countries, notably in Sub-Saharan Africa. Fighting malaria requires significant financial 
and organizational resources, yet malaria itself restrains economic development, 
threatening a vicious circle. We explored these linkages using a cross-country dataset on 
malaria, growth and other country characteristics. The study yielded two main results. 
First, while we confirmed prior research on the importance of climate as a determinant of 
malaria morbidity, we found that geography is not entirely destiny: controlling for 
climate, lower poverty ratios --- enabling even poorer households to invest in anti-malaria 
protection --- are associated with lower malaria morbidity.  Second, we found a quite 
robust negative baseline growth effect of –0.000064 for malaria morbidity per 100,000 
population, reducing annual per capita growth by a quarter percent for the most affected 
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The dataset comprises three years, 1983, 1988 and 1993. In a few cases data are missing, 
the total number of observations on malaria morbidity is 280. Missing information on 
other variables drops the number of observations for the growth regressions reported in 
Table 7 to 187 (78 countries). In the following list, countries that are included in the 




Afghanistan,  Algeria,  Angola, Argentina, Armenia,  Azerbaijan, Bangladesh, Belize, 
Benin, Bhutan, Bolivia, Botswana, Brazil, Burkina Faso, Burundi, Cambodia, 
Cameroon, Cape Verde, Central African Republic, Chad, China, Colombia, 
Comoros, Congo, Democratic Republic of Congo, Costa Rica, Cote d'Ivoire, 
Djibouti,  Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, 
Eritrea, Ethiopia, French Guyana, Gabon, The Gambia, Ghana, Guatemala, Guinea, 
Guinea-Bissau, Guyana, Haiti, Honduras, India, Indonesia, Iran, Iraq, Kenya, South 
Korea, Lao, Liberia, Madagascar, Malawi, Malaysia, Maldives, Mali, Mauritania, 
Mauritius, Mexico, Morocco, Myanmar, Namibia, Nepal, Nicaragua, Niger, Nigeria, 
Oman, Pakistan, Panama, Papua New Guinea, Paraguay, Peru, Philippines, 
Rwanda, Sao Tome and Principe, Saudi Arabia, Senegal, Solomon Islands, Somalia, 
South Africa, Sri Lanka, Sudan, Suriname, Swaziland,  Syrian Arab Republic, 
Tajikistan,  Tanzania,  Thailand, Togo, Turkey, Uganda, United Arab Emirates, 
Vanuatu, Venezuela, Vietnam, Yemen, Zambia, Zimbabwe. 
 